Skip to main content
Log in

Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report

  • Fertility Preservation
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To report the first occurrence of successful ovarian stimulation, oocyte retrieval and oocyte cryopreservation for fertility preservation in an adolescent with severe sickle cell disease scheduled to undergo a hematopoietic stem cell transplant

Methods

Case report

Results

A 19 year old female with severe sickle cell disease presented for fertility preservation counseling prior to hematopoietic stem cell transplantation. She ultimately underwent ovarian stimulation using a minimal stimulation GnRH antagonist protocol resulting in the successful banking of oocytes prior to transplant. The unique hazards associated with ovarian stimulation in patients with sickle cell disease, such as thrombosis and vaso-occlusive events, are discussed and the methods undertaken to minimize these risks are described.

Conclusions

Controlled ovarian hyperstimulation and oocyte banking for fertility preservation is feasible in young women with sickle cell disease requiring hematopoietic stem cell transplant and deserves further investigation. Given the elevated risk of thrombosis and predisposition to painful vaso-occlusive events, controlled ovarian hyperstimulation in patients with sickle cell disease is not straightforward and requires a multi-disciplinary team approach to adequately address and minimize the risks in this unique patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abboud RM. Hematopoietic stem-cell transplantation for adults with sickle cell disease. N Engl J Med. 2009;361(24):2380–81.

    Article  PubMed  CAS  Google Scholar 

  2. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–94.

    PubMed  CAS  Google Scholar 

  3. Minter KR, Gladwin MT. Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. Am J Respir Crit Care Med. 2001;164(11):2016–19.

    PubMed  CAS  Google Scholar 

  4. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–44.

    Article  PubMed  CAS  Google Scholar 

  5. Walters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F, Buchanan GR, Bunin N, Dickerhoff R, Giller R, et al. Pulmonary, gonadal and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant. 2010;16:263–72.

    Article  PubMed  Google Scholar 

  6. Sklar C. Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr. 2005:25–7.

  7. Schimmer AD, Quatermain M, Imrie K, Ali V, McCRae J, Stewart AK, Crump M, Derzko C, Keating A. Ovarian function after autologous bone marrow transplantation. J Clin Oncol. 1998;16:2359–63.

    PubMed  CAS  Google Scholar 

  8. Thibaud E, Rodriguez-Macias K, Trivin C, Esperou H, Michon J, Brauner R. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant. 1998;21:287–90.

    Article  PubMed  CAS  Google Scholar 

  9. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997;130:210–6.

    Article  PubMed  CAS  Google Scholar 

  10. Matsumoto M, Shinohara O, Ishiguro H, et al. Ovarian function after bone marrow transplantation performed before menarche. Arch Dis Child. 1999;80:452–4.

    Article  PubMed  CAS  Google Scholar 

  11. Sanders JE, Hawley J, Levy W, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045–52.

    PubMed  CAS  Google Scholar 

  12. Mayer EI, Dopfer RE, Klingebiel T, Scheel-Walter H, Ranke MB, Neithammer D. Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatr Translant. 1999;3(1):38–44.

    Article  CAS  Google Scholar 

  13. Vlachapapodopoulou E, Kitra V, Peristeri J, Goussetis E, Karachaliou F, Petropoulos D, Fotinou A, Michalacos S, Graphakos S. Gonadal function of young patients with beta-thalassemia following bone marrow transplantation. J Pediatr Endocrinol Metab. 2005;18(5):477–83.

    Article  Google Scholar 

  14. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18:769–76.

    Article  PubMed  CAS  Google Scholar 

  15. Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med. 2003;115:721–28.

    Article  PubMed  CAS  Google Scholar 

  16. Charneski L, Congdon HB. Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: a review of the literature. Am J Health Syst Pharm. 2010;67:895–900.

    Article  PubMed  CAS  Google Scholar 

  17. Smith GD, Serafina PC, Fioravanti J, Yadid I, Coslovsky M, Hassun P, Alegretti JR, Motta EL. Prospective randomized comparison of human oocytes cryopreservation with slow-rate freezing or vitrification. Fertil Steril. 2010;94(6):2088–95.

    Article  PubMed  Google Scholar 

  18. Shalet SM, Didi M, Ogilvy-Stuart AL, Schulga J, Donaldson MD. Growth and endocrine function after bone marrow transplantation. Clin Endocrinol (Oxf). 1995;42:333–9.

    Article  CAS  Google Scholar 

  19. Schubert MA, Sullivan KM, Schubert MM, et al. Gynecological abnormalities following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1990;5:425–30.

    PubMed  CAS  Google Scholar 

  20. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917–31.

    Article  PubMed  Google Scholar 

  21. Cobo A, Domingo J, Perez S, Crespo J, Remohi J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol. 2008;10:268–73.

    Article  PubMed  CAS  Google Scholar 

  22. Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86:70–80.

    Article  PubMed  Google Scholar 

  23. Practice Committee of the American Society of Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008;90:S241–246.

    Google Scholar 

  24. Donnez J, Silbers S, Andersen CY, Demeestere I, Piver P, Meirow D, Pellicer A, Dolmans MM. Children born after autotransplantation of cryopreserved ovarian tissue: a review of 13 live births. Ann Intern Med. 2011;43:437–50.

    Google Scholar 

  25. Roux C, Amiot C, Agnani G, Aubard Y, Rohrlich PS, Piver P. Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation. Fertil Steril. 2010;93(7):2413.e15–9.

    Article  Google Scholar 

  26. Kirkpatrick MB, Haynes J. Sickle cell disease and the pulmonary circulation. Semin Respir Crit Care Med. 1994;15:473–81.

    Article  Google Scholar 

  27. Ataga KI. Hypercoagulability and thrombotic complications in hemolytic anemia. Hematologica. 2009;94(11):1481–84.

    Article  CAS  Google Scholar 

  28. Villers MS, Jamison MG, DeCastro LM, James AH. Morbidity associated with sickle cell disease in pregnancy. Am J Obste Gynecol. 2008;199:125.e1–5.

    Article  Google Scholar 

  29. American College of Obstetricians and Gynecologists Practice Bulletin. Use of hormonal contraception in women with coexisting medical conditions. ACOG Practice Bulletin No 73; 2006:1–20.

    Google Scholar 

  30. Chan WS, Dixon ME. The “ART” of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res. 2008;121:713–26.

    Article  PubMed  CAS  Google Scholar 

  31. Stewart JA, Hamilton PJ, Murdoch AP. Thromboembolic disease associated with ovarian stimulation and assisted conception techniques. Hum Reprod. 1997;12(10):2167–73.

    Article  PubMed  CAS  Google Scholar 

  32. Vloeberghs V, Peeraer K, Pexsters A, D’Hooghe T. Ovarian hyperstimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol. 2009;23:691–709.

    Article  PubMed  Google Scholar 

  33. Kol S, Itskovitz-Eldor J. Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome—a 20 year experience. Semin Reprod Med. 2010;28(6):500–5.

    Article  PubMed  CAS  Google Scholar 

  34. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective, randomized controlled study. Fertil Steril. 2008;89(1):84–91.

    Article  PubMed  CAS  Google Scholar 

  35. Stuart MJ, Nagel R. Sickle-cell disease. Lancet. 2004;364:1343–60.

    Article  PubMed  Google Scholar 

  36. National Institute of Health, National Heart, Lung and Blood Institute, Division of Blood Diseases and Resources. The management of sickle cell disease. NIH Publication No 02-2117, 4th edition, 2002: 1–188

  37. Ballas SK. Sickle cell anaemia: progress in pathogenesis and treatment. Drugs. 2002;62(8):1143–72.

    Article  PubMed  CAS  Google Scholar 

  38. Benjamin LJ, Dampier CD, Jacox AK et al. Guidelines for the management of acute and chronic pain in sickle cell disease. APS clinical practice guideline series no 1. Glenview, IL, 1999.

  39. Morrissey LK, O’Brian Shea J, Kalish LA, Weiner DL, Branowicki P, Heeney MW. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain. Pediatr Blood Cancer. 2009;52:369–72.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None to disclose

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Serena Dovey.

Additional information

Capsule Successful ovarian stimulation, vaginal egg retrieval, and oocyte cryopreservation in a patient with severe sickle cell disease was performed for fertility preservation prior to hematopoietic stem cell transplantation, and the interventions taken to minimize the risks of ovarian stimulation in this patient with significant medical comorbidities are described.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dovey, S., Krishnamurti, L., Sanfilippo, J. et al. Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report. J Assist Reprod Genet 29, 265–269 (2012). https://doi.org/10.1007/s10815-011-9698-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-011-9698-2

Keywords

Navigation